Substantial large-scale clinical cohorts also indicated that alterations in plasma HMW-adiponectin level may be more relevant in the prediction of insulin resistance and metabolic syndrome than total adiponectin levels [8–11]. Here, ADIPOQ is linked to metabolic syndrome.